Please login to the form below

Not currently logged in
Email:
Password:

TOPRA awards open for 2011

Regulatory Affairs organisation launches second annual awards programme

Nominations have opened for the second Regulatory Affairs Awards, run by The Organisation for Professionals in Regulatory Affairs (TOPRA). Building on the success of the first event, held in 2010, there are seven categories this year that pay tribute to those who significantly contribute to the delivery of safe and effective medical therapies to the market place.

Lynda Wight, TOPRAs executive director, commented: "These awards recognise excellence in regulatory affairs in the healthcare sector, celebrating all that is best about the regulatory profession and the people in it. We are pleased to announce that the awards have been expanded to include two additional categories: Communication and Education."

Last years winners were from pharma companies, consultancies and agency, representing professionals from every area of the regulatory community.

With two new sections, the seven different award categories enable people in all stages of their career and within all sectors of the healthcare regulatory industry to receive recognition. The categories for 2011 are: Achievement, Communication, Education, Horizon, Innovation, Inspiration and Support.

The event is supported by an eminent panel of judges from government relations, industry, the legal profession and academia. It will culminate in a gala dinner and ceremony at the Four Seasons Hotel, Canary Wharf, London, UK, on November 24, 2011.

More details at: www.regulatoryaffairsawards.org

9th March 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Cello Health

Cello Health’s mission is to help our clients unlock the potential that exists with their assets, brands and organisations in...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics